Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Dermatol Online J ; 28(3)2022 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-36259803

RESUMEN

Lucio phenomenon is a rare vasculopathy that can occur in patients with Hansen disease, particularly diffuse lepromatous leprosy. It is characterized by retiform purpura and necrotic ulcerations, most commonly affecting the extremities. Diagnosing Lucio phenomenon can be challenging, especially when secondary bacterial infections occur. We report a patient with Lucio phenomenon who presented with acute necrotizing fasciitis of his left upper extremity and a 10-year history of chronic ulcerations. Shortly following admission, he also developed acute kidney injury. The necrotizing fasciitis was treated with prompt surgical debridement and intravenous antibiotics. Biopsy and PCR of a right upper extremity ulcer confirmed the presence of Mycobacterium lepromatosis. Multidrug therapy and prednisone were used to treat the Lucio phenomenon. After initiating treatment, no new lesions developed, kidney function improved, and the patient underwent successful skin graft of his left upper extremity. Although corticosteroid use is controversial, our patient's marked response to multidrug therapy with prednisone highlights the importance of this regimen in severe presentations of Lucio phenomenon. To the best of our knowledge, only two other cases of Lucio phenomenon confirmed to be caused by M. lepromatosis have been reported in living patients (rather than retrospectively identified post-mortem), underscoring the importance of the presented clinical course and treatment regimen.


Asunto(s)
Lesión Renal Aguda , Fascitis Necrotizante , Paniculitis , Enfermedades Vasculares , Masculino , Humanos , Leprostáticos/uso terapéutico , Prednisona/uso terapéutico , Fascitis Necrotizante/complicaciones , Fascitis Necrotizante/diagnóstico , Fascitis Necrotizante/terapia , Quimioterapia Combinada , Estudios Retrospectivos , Paniculitis/tratamiento farmacológico , Lesión Renal Aguda/etiología , Lesión Renal Aguda/tratamiento farmacológico , Corticoesteroides
2.
J. bras. nefrol ; 41(1): 152-156, Jan.-Mar. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1002430

RESUMEN

ABSTRACT Rapidly progressive glomerulonephritis (RPGN) is a renal disease with an extensive differential diagnosis. This paper reports the case of a 55-year-old female patient diagnosed with Hansen's disease with acute progressive renal impairment after developing lower limb pyoderma. The association between Hansen's and kidney disease has been well documented, with glomerulonephritis (GN) ranked as the most common form of renal involvement. Post-infectious glomerulonephritis (PIGN) in adults has been associated with a number of pathogens occurring in diverse sites. The patient described in this case report had RPGN and biopsy findings suggestive of PIGN with C3 and IgA detected on immunofluorescence and kidney injury secondary to recent infection by Staphylococcus, a well-documented manifestation of renal impairment in patients with Hansen's disease.


RESUMO A Glomerulonefrite Rapidamente Progressiva (GNRP) é um padrão de doença renal com amplo diagnóstico diferencial. O caso reporta uma paciente de 55 anos com deterioração aguda e progressiva da função renal após quadro de piodermite em membro inferior com diagnóstico concomitante de hanseníase. Associação da hanseníase com doença renal é bem descrita, sendo a GN a forma de acometimento renal mais comum. As glomerulonefrites pós-infecciosas (GNPIs) em adultos ocorrem devido a um grande número de patógenos, nos mais diversos sítios. A paciente do caso relatado apresentava quadro de GNRP e achados de biópsia que sugerem GNPI com marcação de C3 e IgA na imunofluorescência, sugestiva de lesão renal secundária a infecção recente por Staphylococcus, uma manifestação bem descrita de doença renal em pacientes com hanseníase.


Asunto(s)
Humanos , Persona de Mediana Edad , Complemento C3/metabolismo , Lepra Multibacilar/diagnóstico , Lesión Renal Aguda/diagnóstico , Glomerulonefritis por IGA/diagnóstico , Rifampin/uso terapéutico , Biopsia , Nitrógeno de la Urea Sanguínea , Técnica del Anticuerpo Fluorescente , Clofazimina/uso terapéutico , Creatinina/sangre , Dapsona/uso terapéutico , Diagnóstico Diferencial , Lesión Renal Aguda/tratamiento farmacológico , Glomerulonefritis por IGA/tratamiento farmacológico , Glucocorticoides/administración & dosificación , Glucocorticoides/uso terapéutico
3.
J Bras Nefrol ; 41(1): 152-156, 2019.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-30160772

RESUMEN

Rapidly progressive glomerulonephritis (RPGN) is a renal disease with an extensive differential diagnosis. This paper reports the case of a 55-year-old female patient diagnosed with Hansen's disease with acute progressive renal impairment after developing lower limb pyoderma. The association between Hansen's and kidney disease has been well documented, with glomerulonephritis (GN) ranked as the most common form of renal involvement. Post-infectious glomerulonephritis (PIGN) in adults has been associated with a number of pathogens occurring in diverse sites. The patient described in this case report had RPGN and biopsy findings suggestive of PIGN with C3 and IgA detected on immunofluorescence and kidney injury secondary to recent infection by Staphylococcus, a well-documented manifestation of renal impairment in patients with Hansen's disease.


Asunto(s)
Lesión Renal Aguda/diagnóstico , Complemento C3/metabolismo , Glomerulonefritis por IGA/diagnóstico , Inmunoglobulina A/metabolismo , Lepra Multibacilar/diagnóstico , Lesión Renal Aguda/tratamiento farmacológico , Biopsia , Nitrógeno de la Urea Sanguínea , Clofazimina/uso terapéutico , Creatinina/sangre , Dapsona/uso terapéutico , Diagnóstico Diferencial , Femenino , Técnica del Anticuerpo Fluorescente , Glomerulonefritis por IGA/tratamiento farmacológico , Glucocorticoides/administración & dosificación , Glucocorticoides/uso terapéutico , Humanos , Riñón/patología , Leprostáticos/uso terapéutico , Persona de Mediana Edad , Prednisona/administración & dosificación , Prednisona/uso terapéutico , Diálisis Renal , Rifampin/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA